Segment Reporting (Tables)

9 Months Ended

Sep. 30, 2013

Segment Reporting (Tables) [Abstract]

Segment Reporting Information By Segment

A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying unaudited condensed consolidated statements of operations is as follows:

	Three Months Ended September 30,						Nine Months Ended September 30,
(in millions)	2013			2012*			2013			2012*
Net sales
Interventional Cardiology	$	487		$	496		$	1,538		$	1,646
Peripheral Interventions	202			188			601			571
Cardiovascular	689			684			2,139			2,217
Cardiac Rhythm Management	474			467			1,445			1,466
Electrophysiology	35			35			106			109
Rhythm Management	509			502			1,551			1,575
Endoscopy	331			308			979			916
Urology/Women's Health	134			124			378			367
Neuromodulation	116			88			316			263
MedSurg	581			520			1,673			1,546
Net sales allocated to reportable segments	1,779			1,706			5,363			5,338
Sales generated from divested businesses	2			32			56			91
Impact of foreign currency fluctuations	(46		)	(3		)	(114		)	(1		)
	$	1,735		$	1,735		$	5,305		$	5,428
Income (loss) before income taxes
Cardiovascular	$	184		$	175		$	548		$	561
Rhythm Management	68			58			192			218
MedSurg	187			169			521			452
Operating income allocated to reportable segments	439			402			1,261			1,231
Corporate expenses and currency exchange	(103		)	(58		)	(251		)	(214		)
Goodwill and other intangible asset impairment charges; and acquisition-, divestiture-, restructuring-, and litigation related charges and credits	(132		)	(839		)	(711		)	(4,708		)
Amortization expense	(101		)	(99		)	(305		)	(294		)
Operating (loss) income	103			(594		)	(6		)	(3,985		)
Other expense, net	(143		)	(69		)	(276		)	(174		)
Income (loss) before income taxes	$	(40	)	$	(663	)	$	(282	)	$	(4,159	)

* We have restated prior year detail to conform to current year presentation.